Trial Profile
A Pilot Study of Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2019
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 29 Sep 2009 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 29 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Feb 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.